Detalles de la búsqueda
1.
Deleterious alterations of DNA damage response and repair genes and clinical benefit to anti-PD-1 therapy in esophageal squamous cell carcinoma.
Esophagus
; 19(4): 693-701, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35816242
2.
Response to Immune Checkpoint Inhibitors in Recurrent or Metastatic Esophageal Squamous Cell Carcinoma May Be Affected by Tumor Sites.
Oncology
; 99(10): 652-658, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34340231
3.
Phase II study of metabolic response to one-cycle chemotherapy in patients with locally advanced esophageal squamous cell carcinoma.
J Formos Med Assoc
; 118(6): 1024-1030, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-30502100
4.
Systematic review and network meta-analysis: neoadjuvant chemoradiotherapy for locoregional esophageal cancer.
Jpn J Clin Oncol
; 45(11): 1023-8, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26246479
5.
Different immune contextures underlie tumor site-specific responses to immune checkpoint blockade in esophageal cancer.
Thorac Cancer
; 14(22): 2216-2221, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37340770
6.
Prognostication and optimal criteria of circumferential margin involvement for esophageal cancer after chemoradiation and esophagectomy.
Front Oncol
; 13: 1111998, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37503328
7.
B Cells in Tumor Microenvironment Associated With The Clinical Benefit to Programmed Cell Death Protein-1 Blockade Therapy in Patients With Advanced Esophageal Squamous Cell Carcinoma.
Front Oncol
; 12: 879398, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35847892
8.
Prognostic value of PD-L1 expression on immune cells or tumor cells for locally advanced esophageal squamous cell carcinoma in patients treated with neoadjuvant chemoradiotherapy.
J Cancer Res Clin Oncol
; 148(7): 1803-1811, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-34432128
9.
Neutrophil-to-lymphocyte Ratio and Use of Antibiotics Associated With Prognosis in Esophageal Squamous Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors.
Anticancer Res
; 39(10): 5675-5682, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31570466
10.
Weekly 24-hour infusional 5-fluorouracil as initial treatment for advanced gastric cancer with acute disseminated intravascular coagulation.
Anticancer Res
; 28(2B): 1293-7, 2008.
Artículo
en Inglés
| MEDLINE | ID: mdl-18505068
11.
Number of Resected Lymph Nodes and Survival of Patients with Locally Advanced Esophageal Squamous Cell Carcinoma Receiving Preoperative Chemoradiotherapy.
Anticancer Res
; 38(3): 1569-1577, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29491087
12.
Postchemoradiotherapy Pathologic Stage Classified by the American Joint Committee on the Cancer Staging System Predicts Prognosis of Patients with Locally Advanced Esophageal Squamous Cell Carcinoma.
J Thorac Oncol
; 10(10): 1481-9, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26313683
13.
Prognostic factors of metastatic or recurrent esophageal squamous cell carcinoma in patients receiving three-drug combination chemotherapy.
Anticancer Res
; 33(9): 4123-8, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-24023359
14.
Comparison of weekly versus every 3 weeks paclitaxel in the treatment of advanced solid tumors: a meta-analysis.
Cancer Treat Rev
; 38(6): 613-7, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-22155063
15.
On predicting clinical response to chemoradiotherapy in esophageal squamous cell carcinoma: additional evaluation by magnetic resonance imaging may help.
Ann Transl Med
; 5(24): 487, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-29299449
16.
Left ventricle metastasis of esophageal cancer mimicking myocardial infarction in myocardial perfusion scintigraphy.
Int J Cardiol
; 167(6): e184-6, 2013 Sep 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-23639460
Resultados
1 -
16
de 16
1
Próxima >
>>